Verrica Pharmaceuticals Inc. Total Long-Term Debt
Verrica Pharmaceuticals Inc. (VRCA) had Total Long-Term Debt of $0 as of 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Balance Sheet › Liabilities › Debt
us-gaap:LongTermDebt · last filed 2026-03-11
- 2025-12-31: Long-term Debt $0.00.
- 2025-09-30: Long-term Debt $21.62M.
- 2025-06-30: Long-term Debt $24.58M.
- 2025-03-31: Long-term Debt $27.81M.
| Period end | Long-term Debt |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-11 |
| 2025-09-30 | $21.62M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $24.58M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $27.81M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $30.98M 10-K · filed 2026-03-11 |
| 2024-09-30 | $43.30M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $42.75M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $42.85M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $42.87M 10-K · filed 2025-03-11 |
| 2023-09-30 | $42.40M 10-Q · filed 2023-11-09 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-29 |
| 2020-03-31 | $34.43M 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |